(Q33467433)

27 July 2017

1 reference

title

The clinical use of immunosuppression (English)

1 reference

27 July 2017

The Clinical Use of Immunosuppression (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

17 March 2023

1 reference

D. W. Watson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4902918

17 March 2023

A. G. Johnson

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4902918

17 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4902918

17 March 2023

publication date

1 November 1969

1 reference

full work available at URL

27 July 2017

https://api.elsevier.com/content/article/PII:S0025712516326979?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

https://api.elsevier.com/content/article/PII:S0025712516326979?httpAccept=text/plain

17 March 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Medical Clinics of North America

17 March 2023

published in

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

1225-1241

1 reference

Idiopathic thrombocytopenic purpura

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Treatment of ulcerative colitis with antimetabolites

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Treatment of Refractory Idiopathic Thrombocytopenic Purpura

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Concepts of Autoimmune Disease and Their Implications for Therapy

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Effect of febrile plasma, typhoid vaccine and nitrogen mustard on renal manifestations of human glomerulonephritis.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Cirrhosis Associated With Methotrexate Treatment of Psoriasis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Azathioprine therapy of ?autoimmune? diseases

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Intra-articular thiotepa in rheumatoid arthritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

The treatment of acquired hemolytic anemia. With a note on the relationship of periarteritis nodosa to hemolytic anemia

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Experimental glomerulonephritis. The pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

COURSE AND PROGNOSIS IN RHEUMATOID ARTHRITIS. A FURTHER REPORT.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Long-term cyclophosphamide therapy in rheumatoid arthritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

AUTOANTIBODY PRODUCTION IN RABBITS. VI. THE PRODUCTION OF AUTOANTIBODIES AGAINST RABBIT GASTRIC, ILEAL AND COLONIC MUCOSA

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Dangers of immunosuppressive drugs in ulcerative colitis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Treatment of collagen diseases with cytostatics.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Response to azathioprine in ulcerative colitis. Report of 7 cases

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Methotrexate for psoriasis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Azathioprine in Rheumatoid Arthritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

The use of ACTH and cortisone in idiopathic thrombocytopenic purpura and idiopathic acquired hemolytic anemia

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Immunosuppressive therapy of chronic renal disease

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Suppression of Rh-immunization by passively administered anti-Rh

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

A Requirement for Two Cell Types for Antibody Formation in vitro

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

SUPPRESSION OF PLASMA CELL HEPATITIS WITH 6-MERCAPTOPURINE

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Suppression of allergic encephalomyelitis in rats by means of antibrain serum

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

A case of idiopathic thrombocytopenia and autoimmune hemolytic anemia treated with thymic irradiation and by administration of imuran and actinomycin-C.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Delayed hypersensitivity in auto-immune disease

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

CYCLOPHOSPHAMIDE TREATMENT OF KIDNEY DISEASE IN (NZB X NZW) F1 MICE

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

19S and 7S Antibody Production in the Cyclophosphamide- or Methotrexate-treated Rat

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Intravenous administration of nitrogen mustard alone and with corticotropin for rheumatoid arthritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Effect of 6-mercaptopurine on antibody production

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Antilymphocytic antibody: effects in experimental animals and problems in human use.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Mercaptopurine in the Treatment of Steroid-Resistant Nephrotic Syndrome

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

DEPRESSION BY ANTIBODY OF THE IMMUNE RESPONSE TO HOMOGRAFTS AND ITS ROLE IN IMMUNOLOGICAL ENHANCEMENT.

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Azathioprine in Refractory Idiopathic Thrombocytopenic Purpura

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Immunosuppressive therapy. The relation between clinical response and immunologic competence

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Treatment of Ulcerative Colitis with Azathioprine

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Regulatory Effect of Antibody on the Immune Response

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

IMMUNOLOGICAL REACTIONS AFTER TISSUE DAMAGE

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

NITROGEN MUSTARD IN THE TREATMENT OF CHRONIC ULCERATIVE COLITIS AND REGIONAL ENTERITIS; A PRELIMINARY REPORT

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

Evaluation of intra-articular thio-tepa in rheumatoid arthritis

17 March 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(16)32697-9

17 March 2023

Identifiers

1 reference